Two Sigma Advisers’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Two Sigma Advisers’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-201,400	Closed	-$5.55M	–	2785
2021 Q2	$5.55M	Sell	201,400 -72,900	-27%	-$1.43M	0.01%	814
2021 Q1	$4.52M	Sell	274,300 -104,400	-28%	-$2.38M	0.01%	889
2020 Q4	$6.98M	Sell	378,700 -51,500	-12%	-$922K	0.02%	701
2020 Q3	$5.86M	Buy	+430,200	New	+$6.63M	0.02%	710

Two Sigma Advisers's TBIO Position: Q3 2021 in Review

Two Sigma Advisers sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 201,400 shares — an estimated $5.55M sold.

Two Sigma Advisers first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $6.98M in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Two Sigma Advisers reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Two Sigma Advisers sold 201,400 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $5.55M.
Two Sigma Advisers first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Two Sigma Advisers's Translate Bio, Inc. Common Stock position peaked at $6.98M in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.